Gene Editing & Genomics
CRISPR and other gene editing technologies allow scientists to precisely modify DNA to treat or cure genetic diseases. For the first time in history, conditions once considered permanent — sickle cell disease, genetic blindness, certain cancers — can potentially be cured with a single treatment.
Co-developed Casgevy with Vertex Pharmaceuticals — the world's first approved CRISPR gene editing therapy, curing sickle cell disease and beta-thalassemia. One of the most significant medical breakthroughs in history. Has a pipeline of cancer and cardiovascular treatments.
Developing in-vivo CRISPR therapies — treatments that edit genes directly inside the patient's body rather than in a lab. This approach could treat diseases in organs that are difficult to reach. Early clinical results have been remarkable.
Scores 10/10 for Gene Editing. Also relevant to Base Editing and Genomics.
Scores 10/10 for Gene Editing. Also relevant to Genomics.
Scores 9/10 for Rare Disease. Also relevant to Gene Therapy.
Scores 9/10 for mRNA Technology. Also relevant to Personalised Medicine.
Scores 9/10 for Liquid Biopsy. Also relevant to Personalised Medicine.
Scores 9/10 for AI in Drug Discovery.
Want to explore how these companies connect to each other?